These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 24240108)
1. HDM2 regulation by AURKA promotes cell survival in gastric cancer. Sehdev V; Katsha A; Arras J; Peng D; Soutto M; Ecsedy J; Zaika A; Belkhiri A; El-Rifai W Clin Cancer Res; 2014 Jan; 20(1):76-86. PubMed ID: 24240108 [TBL] [Abstract][Full Text] [Related]
2. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Katsha A; Soutto M; Sehdev V; Peng D; Washington MK; Piazuelo MB; Tantawy MN; Manning HC; Lu P; Shyr Y; Ecsedy J; Belkhiri A; El-Rifai W Gastroenterology; 2013 Dec; 145(6):1312-22.e1-8. PubMed ID: 23993973 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib. Wang L; Arras J; Katsha A; Hamdan S; Belkhiri A; Ecsedy J; El-Rifai W Mol Oncol; 2017 Aug; 11(8):981-995. PubMed ID: 28417568 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1. Wang-Bishop L; Chen Z; Gomaa A; Lockhart AC; Salaria S; Wang J; Lewis KB; Ecsedy J; Washington K; Beauchamp RD; El-Rifai W Gastroenterology; 2019 Feb; 156(3):662-675.e7. PubMed ID: 30342037 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells. Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines. Liu N; Wang YA; Sun Y; Ecsedy J; Sun J; Li X; Wang P Respir Res; 2019 Oct; 20(1):230. PubMed ID: 31647033 [TBL] [Abstract][Full Text] [Related]
7. Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Dar AA; Zaika A; Piazuelo MB; Correa P; Koyama T; Belkhiri A; Washington K; Castells A; Pera M; El-Rifai W Cancer; 2008 Apr; 112(8):1688-98. PubMed ID: 18311783 [TBL] [Abstract][Full Text] [Related]
8. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. Sehdev V; Peng D; Soutto M; Washington MK; Revetta F; Ecsedy J; Zaika A; Rau TT; Schneider-Stock R; Belkhiri A; El-Rifai W Mol Cancer Ther; 2012 Mar; 11(3):763-74. PubMed ID: 22302096 [TBL] [Abstract][Full Text] [Related]
9. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells. Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841 [No Abstract] [Full Text] [Related]
10. The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas. Sehdev V; Katsha A; Ecsedy J; Zaika A; Belkhiri A; El-Rifai W Cancer; 2013 Feb; 119(4):904-14. PubMed ID: 22972611 [TBL] [Abstract][Full Text] [Related]
11. Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models. Kogiso M; Qi L; Braun FK; Injac SG; Zhang L; Du Y; Zhang H; Lin FY; Zhao S; Lindsay H; Su JM; Baxter PA; Adesina AM; Liao D; Qian MG; Berg S; Muscal JA; Li XN Clin Cancer Res; 2018 May; 24(9):2159-2170. PubMed ID: 29463553 [No Abstract] [Full Text] [Related]
12. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion. Do TV; Xiao F; Bickel LE; Klein-Szanto AJ; Pathak HB; Hua X; Howe C; O'Brien SW; Maglaty M; Ecsedy JA; Litwin S; Golemis EA; Schilder RJ; Godwin AK; Connolly DC Oncogene; 2014 Jan; 33(5):539-49. PubMed ID: 23334327 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929 [TBL] [Abstract][Full Text] [Related]
14. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer. Dauch D; Rudalska R; Cossa G; Nault JC; Kang TW; Wuestefeld T; Hohmeyer A; Imbeaud S; Yevsa T; Hoenicke L; Pantsar T; Bozko P; Malek NP; Longerich T; Laufer S; Poso A; Zucman-Rossi J; Eilers M; Zender L Nat Med; 2016 Jul; 22(7):744-53. PubMed ID: 27213815 [TBL] [Abstract][Full Text] [Related]
15. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma. Liu Q; Mier JW; Panka DJ Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745 [TBL] [Abstract][Full Text] [Related]
16. Kinase inhibitor screening reveals aurora-a kinase is a potential therapeutic and prognostic biomarker of gastric cancer. Mesquita FP; Lucena da Silva E; Souza PFN; Lima LB; Amaral JL; Zuercher W; Albuquerque LM; Rabenhorst SHB; Moreira-Nunes CA; Amaral de Moraes ME; Montenegro RC J Cell Biochem; 2021 Oct; 122(10):1376-1388. PubMed ID: 34160883 [TBL] [Abstract][Full Text] [Related]
17. A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma. Yi H; Yan X; Luo Q; Yuan L; Li B; Pan W; Zhang L; Chen H; Wang J; Zhang Y; Zhai Y; Qiu MZ; Yang DJ J Exp Clin Cancer Res; 2018 May; 37(1):97. PubMed ID: 29716622 [TBL] [Abstract][Full Text] [Related]
18. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo. Koblish HK; Zhao S; Franks CF; Donatelli RR; Tominovich RM; LaFrance LV; Leonard KA; Gushue JM; Parks DJ; Calvo RR; Milkiewicz KL; Marugán JJ; Raboisson P; Cummings MD; Grasberger BL; Johnson DL; Lu T; Molloy CJ; Maroney AC Mol Cancer Ther; 2006 Jan; 5(1):160-9. PubMed ID: 16432175 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer. Pitts TM; Bradshaw-Pierce EL; Bagby SM; Hyatt SL; Selby HM; Spreafico A; Tentler JJ; McPhillips K; Klauck PJ; Capasso A; Diamond JR; Davis SL; Tan AC; Arcaroli JJ; Purkey A; Messersmith WA; Ecsedy JA; Eckhardt SG Oncotarget; 2016 Aug; 7(31):50290-50301. PubMed ID: 27385211 [TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer. Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]